Wczytywanie kursów wyceny...
Prognoza
Średnia cena docelowa analityków wynosi 54,23 € (+88,36%). Mediana wynosi 51,80 € (+79,92%).
| Kupuj |
4 |
| Trzymaj |
18 |
| Sprzedaj |
1 |
Dyskusje w społeczności
Nie ma jeszcze dyskusji o tym aktywie.
Rozpocznij dyskusjęWiadomości Przejdź do aktualności
Calumet misses Q1 2026 earnings forecasts despite progress in renewable fuels
Calumet reported Q1 2026 earnings per share of -$3.64, missing analysts’ expectation of -$0.31, while revenue of $1.03 billion slightly exceeded estimates. A production outage in Shreveport due to organic chloride contamination cost about 750,000 barrels and roughly $30 million, which pushed adjusted EBITDA down to $50.1 million. Montana Renewables showed strong operational improvements (adjusted EBITDA +209%) and the MaxSAF-150 expansion began operations, while the new SET-2 RVO has significantly increased demand for biofuels and improved margins. Management expects that the resumption of production and a better market environment will lead to improved results in 2026, but continues to see challenges with the debt structure. » Więcej na de.investing.com
Calumet announces quarterly results for 31 March 2026, analysts see significantly smaller loss
Calumet expects to release results for the quarter ended 31 March 2026 on 8 May 2026. Five analysts on average expect earnings per share of -$0.333 versus -$1.870 in the year‑ago quarter. Six analysts forecast revenue of around $1.01 billion (+1.93% year‑on‑year). For the current fiscal year the consensus estimate is $0.077 per share and revenue of about $4.41 billion. » Więcej na finanzen.net
Calumet: supervisory board member Jennifer Straumins will not stand for re-election in 2026
Jennifer Straumins will not stand for re-election to Calumet’s supervisory board at the annual general meeting in 2026 and will leave the board at the end of her term. Straumins has been a member of the supervisory board since July 2024; she was previously a member of the board of Calumet GP, LLC and worked for the company for 13 years. She currently serves on the strategy and growth committee and the risk committee; the supervisory board now intends to review the composition and competencies of the body. » Więcej na de.investing.com
Calumet cuts debt by $220 million, Q4 profitability remains weak
Calumet reported adjusted EBITDA of $293.3 million for 2025 and highlighted a reduction in restricted liabilities of more than $220 million. Despite cost cuts and higher production, the company missed Q4 estimates by a wide margin; diluted EPS was -$0.43 versus -$0.22 expected. The Specialty Products segment showed strong margins, while Montana Renewables was weighed down by low industry margins and transaction costs. Management emphasizes debt reduction, cash-flow improvement and the MaxSAF150 project (completion Q2 2026) as key levers to restore profitability. » Więcej na de.investing.com
S&P raises outlook for Calumet to positive after refinancing
S&P Global Ratings has raised the outlook for Calumet from "stable" to "positive" and affirmed the rating at CCC+ after the company refinanced short-term liabilities by issuing unsecured bonds and extended the ABL maturity. S&P expects improvements in credit metrics over the next 12 months, with EBITDA margins projected to rise by about 200 basis points to roughly 8% in 2025 and to approach the 10% mark in 2026/27. Calumet’s subsidiary Montana Renewables plans to increase SAF capacity in Q2 2026 to 120–150 million gallons, and contracts already signed cover much of the expansion. Risks remain from commodity price and regulatory exposure and possible RIN-related obligations that could strain liquidity and metrics. » Więcej na de.investing.com
Historyczne dywidendy Dywidendy
Wszystkie wskaźniki dywidendowe Wszystkie wskaźnikiDane finansowe spółki
| (EUR) | wrzesień 2026 | YoY |
|---|---|---|
| Przychody | 1,49 mld | 61,74% |
| Zysk brutto | 479,56 mln | 50,60% |
| Zysk netto | 226,36 mln | 15,24% |
| EBITDA | 293,72 mln | 0,09% |
Dane fundamentalne
| Wskaźnik | Wartość |
|---|---|
Kapitalizacja rynkowa | 2,59 mld € |
Liczba akcji | 88,09 mln |
Maksimum/minimum z 52 tygodni | 54,41 € - 16,22 € |
| Dywidendy | Nie |
Beta | 0,78 |
C/Z (PE Ratio) | -14,37 |
PEG (PEG Ratio) | 0,04 |
C/WK (PB Ratio) | -3,27 |
C/S (PS Ratio) | 0,55 |
Profil spółki
Calumet Specialty Products Partners, L.P. wytwarza, formułuje i sprzedaje szeroką gamę specjalistycznych produktów markowych dla różnych rynków konsumenckich i przemysłowych w Ameryce Północnej oraz na świecie. Jej segment Specialty Products and Solutions oferuje różne rozpuszczalniki, woski, dostosowywane oleje smarne, oleje białe, wazeliny, żele, estry i inne produkty. Segment Montana/Renewables koncentruje się na przetwarzaniu surowców odnawialnych na wodór odnawialny, gaz ziemny odnawialny, propan odnawialny, naftę odnawialną, paliwo lotnicze/naftę odnawialną oraz olej napędowy odnawialny. Segment ten przetwarza również kanadyjską ropę naftową na konwencjonalną benzynę, olej napędowy, paliwo lotnicze oraz specjalistyczne gatunki asfaltu. Jej segment Performance Brands miesza, pakuje i sprzedaje wysokowydajne produkty pod markami Royal Purple, Bel-Ray i TruFuel. Calumet GP, LLC pełni funkcję komplementariusza spółki Calumet Specialty Products Partners, L.P. Firma została założona w 1916 roku i ma siedzibę w Indianapolis w stanie Indiana.
| Nazwa | Calumet Spec. Prods Part. ADR |
| CEO | Louis Todd Borgmann |
| Siedziba | Indianapolis,
in Stany Zjednoczone |
| Strona internetowa | |
| Sektor | Energetyka |
| Branża | Ropa naftowa, gaz i paliwa nieodnawialne |
| Debiut giełdowy | 26.01.2006 |
| Pracownicy | 1540 |
Symbole giełdowe
| Giełda | Symbol |
|---|---|
NASDAQ | CLMT |